HOC is our outreach and engagement site which connects us with healthcare professionals, industry personnel and academics worldwide.
Our HOC platform shares blogs from experienced medical writers around the world, bringing you tips on good communication, evaluations of current health economics and outcomes research and healthcare evidence. Mixed in with great information you will find a light-hearted approach to current issues, some valuable downloads, as well as references for further reading.
By Mary Gabb (mary.gabb@rxcomms.com ) The publication several years ago of Selling Sickness: How the World’s Biggest Pharmaceutical Companies are Turning Us All into Patients by Ray Moynihan and Alan…
Details
The US Food and Drug Administration (FDA) in August proposed a new guideline asking the sponsors of clinical trials to submit annual development safety update reports (DSURs). The guideline, titled “E2F Development Safety Update Report,” is in draft form and describes the format, content, and timing of a DSUR.
Details
By Julie Stauffer (julie.stauffer@rxcomms.com) How quickly can you lay your hands on tomorrow’s meeting agenda, the latest batch of clinical data, or the draft report you’ve been asked to review?…
Details
By David Woods (david.woods@rxcomms.com) “Since 2000, the US Food and Drug Administration (FDA) has received more than 95,000 reports of medication errors. These reports are voluntary, so the number of…
Details
After selling his travel company – the third largest in the US – to American Express for $6 billion, Hal Rosenbluth could have spent his time fishing, golfing, or globetrotting; instead, he co-founded Take Care Health Systems.
Details
By Duncan Dibble (duncan.dibble@rxcomms.com ) If you Google for ‘website’ and ‘traffic’ you’ll be inundated with miracle cures to increase visitors to your site. It will then take you roughly…
Details
By David Woods ( david.woods@rxcomms.com ) The Association of American Medical Colleges (AAMC) recently issued a 43-page report of its task force on industry funding of medical education. Sections of…
Details
By David Woods (david.woods@rxcomms.com) Journal editors reject submitted manuscripts because they are: Inappropriate for their audience Poorly designed studies Poorly written Seen to have been submitted elsewhere Suspected of conflict…
Details
By Mary Gabb ( mary.gabb@rxcomms.com ) A negative result is defined as one that shows evidence of absent (or no) effect of an intervention; it is not due to absence…
Details
By Ruth Whittington (ruth.whittington@rxcomms.com) With the NHS in the UK nearing its 60th birthday, there’s been considerable talk about whether the system should be put into retirement. At the recent…
Details
